Description of Research Expertise
Investigator, Multicenter Trials in the Management of Lipids and Cardiovascular Risk:
CRISP: A single arm open label study of a statin in community-based patients with cardiovascular disease. Mayo Alliance for Clinical Trials. (2000-2001)
AIM-HIGH: Trial examining the safety and effectiveness of a combination regimen of extended release niacin and simvastatin vs simvastatin alone for prevention of cardiovascular events in patients with cardiovascular disease and low HDL/high triglycerides. NIH sponsored. (2006-present; study stopped in 2011)
DAL-OUTCOMES: Multi-centered trial evaluating the efficacy, safety and clinical outcomes of treatment with dalcetrapib, a CETP modulating agent which raises HDL, in the treatment of who have experienced an acute coronary syndrome. Industry sponsored. (2009-present; recruitment complete)
ALECARDIO: Multi-centered trial evaluating cardiovascular outcomes of treatment with aleglitizar, a dual PPAR inhibitor, in the treatment of diabetics who have experienced an acute coronary syndrome. Industry sponsored. (2010-present; recruitment in progress)
Academic Contact Information
Penn Heart and Vascular Center at Pennsylvania Hospital
Farm Journal Building, Third Floor,
230 West Washington Square
Philadelphia,
PA
19106
Phone: 215-829-5064
Patient appointments: 800-789-7366